C. Pulcini
Impact in
- Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
- Health top 0.5%
- Vaccine Coverage and Hesitancy
Papers in
-
- Antibiotic Use and Resistance 42
- Epidemiology 32
- Urinary Tract Infections Management 9
- Pneumonia and Respiratory Infections 6
- Co-authors
- Pierre Verger (20 shared papers)Dilip Nathwani (11 shared papers)Inge C. Gyssens (2 shared papers)Stephan Harbarth (7 shared papers)Oliver J. Dyar (7 shared papers)Lisa Fressard (9 shared papers)Odile Launay (8 shared papers)Fanny Collange (7 shared papers)
- Journals
- Clinical Microbiology and Infection (13 papers)European Journal of Clinical Microbiology & Infectious Diseases (13 papers)Journal of Antimicrobial Chemotherapy (8 papers)Vaccine (6 papers)Infection (4 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
C. Pulcini
114 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 127
- Applied Microbiology and Biotechnology 1.6k
- Health 622
- Molecular Medicine 288
- Geriatrics and Gerontology 175
- Clinical Biochemistry 335
Countries citing papers authored by C. Pulcini
This map shows the geographic impact of C. Pulcini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Pulcini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Pulcini more than expected).
Fields of papers citing papers by C. Pulcini
This network shows the impact of papers produced by C. Pulcini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Pulcini. The network helps show where C. Pulcini may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Pulcini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 256 | |
| 2 | 2013 | 212 | |
| 3 | 2014 | 207 | |
| 4 | 2010 | 189 | |
| 5 | Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe | 2018 | 178 |
| 6 | 2013 | 150 | |
| 7 | 2018 | 135 | |
| 8 | 2010 | 120 | |
| 9 | 2019 | 86 | |
| 10 | 2014 | 82 | |
| 11 | 2011 | 79 | |
| 12 | 2013 | 78 | |
| 13 | 2014 | 76 | |
| 14 | 2017 | 76 | |
| 15 | 2007 | 74 | |
| 16 | 2013 | 72 | |
| 17 | 2013 | 71 | |
| 18 | 2006 | 70 | |
| 19 | 2016 | 67 | |
| 20 | 2016 | 64 |
About C. Pulcini
C. Pulcini is a scholar working on Applied Microbiology and Biotechnology, Epidemiology, Infectious Diseases, Health and General Health Professions, having authored 117 papers that have together received 3.8k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (42 papers), Vaccine Coverage and Hesitancy (15 papers), Bacterial Identification and Susceptibility Testing (12 papers), Urinary Tract Infections Management (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Patient Satisfaction in Healthcare (9 papers), Streptococcal Infections and Treatments (8 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.6k citations), Health (622 citations), Molecular Medicine (288 citations), Geriatrics and Gerontology (175 citations) and Clinical Biochemistry (335 citations). C. Pulcini has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Pierre Verger, Dilip Nathwani, Inge C. Gyssens, Stephan Harbarth, Oliver J. Dyar, Lisa Fressard, Odile Launay, Fanny Collange, Philip Howard and Patrick Peretti‐Watel. Their work appears in journals such as Clinical Microbiology and Infection, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Vaccine and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.